Blood Exchange Cuts Death Rate from Rare Tick Disease 73%

Scientists just discovered a treatment that could save lives from a dangerous tick-borne disease most people have never heard of.

A massive 15-year study involving 82 hospitals found that red blood cell exchange transfusion reduces death and hospital readmission rates by 73 percent in severe babesiosis cases. The research, led by Harvard Medical School's Dr. David Leaf, analyzed 3,000 patients and represents the largest clinical study ever conducted on the rare disease.

Babesiosis, sometimes called Nantucket Fever, causes a parasite to attack red blood cells, leading to fever, fatigue, severe anemia, and sometimes death. While only about 2,000 cases are officially reported in the United States each year, experts believe the true number is much higher since many mild cases go undiagnosed.

The numbers tell a powerful story. Among critically ill patients who received the exchange transfusion, just 3.6 percent died or needed hospital readmission within 30 days. Without the treatment, that number jumped to 9.8 percent.

The procedure works by circulating a patient's blood through a machine that removes infected red blood cells and replaces them with healthy donor cells. It's invasive and reserved for the most severe cases, but Dr. Peter Krause, the study's senior author, says it can be lifesaving.

"If I were to explain the importance of this study to someone, especially at high risk, I would say you can derive a little bit of comfort from this," Krause told reporters. Dr. Leaf added that severe cases require getting to a hospital equipped to perform the procedure quickly.

The Bright Side

The study almost didn't happen. Babesiosis is so rare that research funding remains scarce, making traditional clinical trials nearly impossible. Instead, more than 100 doctors and scientists volunteered their time and data in what Leaf calls "a grassroots, investigator-initiated effort."

Their collaboration represents something bigger than one disease. It shows how community-driven research can tackle important health questions even when money is tight.

The timing matters too. Like other tick-borne illnesses, babesiosis cases are climbing as climate change allows tick populations to expand into new areas. Better recognition of severe cases and access to effective treatments will become increasingly critical as more people encounter infected ticks.

This breakthrough gives doctors their first large-scale evidence for treating the worst cases of a disease that's been quietly spreading for years.